In national news:

The FDA released a statement yesterday indicating that it is preparing a new, more restrictive policy targeting what drugs compounding pharmacies can produce that do not go through the agency’s approval process. FDA Commissioner Scott Gottlieb said the agency in March will issue draft guidance with new criteria for determining what substances can be used to produce drugs in bulk for hospitals and doctors’ offices without individual patient prescriptions.

Read more from Reuters here.

Leave a Comment

Your email address will not be published. Required fields are marked *